Pilot Conversion Study From Mycophenolate Mofetil to Everolimus in Stable ABO-Incompatible Kidney Transplant Recipients: Analysis of 1-Year Follow-Up Data.

CONCLUSIONS: Everolimus elicited no acute rejection and no C4d deposition, whether everolimus was maintained or stopped within 1 year after conversion, in ABO-incompatible kidney transplant recipients. PMID: 30198840 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30198840?dopt=Abstract

Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - September 4, 2018 Category: Transplant Surgery Authors: Uchida J, Iwai T, Nishide S, Kabei K, Kuwabara N, Naganuma T, Kumada N, Takemoto Y, Nakatani T Tags: Exp Clin Transplant Source Type: research